Botnar Research Centre, Old Road, Headington, Oxford, OX3 7LD
- 2015 Hunterian Professor, Royal College of Surgeons of England
- 2014 Ronald Raven Prize, British Association of Surgical Oncology, Anninga B & Douek M.
- 2004 Distinguished Teacher Award, Royal Free and University College Medical School, London
- 2003 Distinguished Teacher Award, Royal Free and University College Medical School, London
- 2003 Clinician Scientist Research Fellowship (Academy of Medical Sciences): awarded full funding for three years at senior lecturer / consultant level
- 2002 Moynihan Travelling Fellowship for 2003
The Rosetrees Royal College of Surgeons of England Academic Director of NDS SITU
- Professor of Surgical Sciences & Breast Cancer
- Honorary Consultant
Professor Michael Douek joined the University of Oxford in March 2019 as The Rosetrees Royal College of Surgeons of England Director of the Surgical Interventional Trials Unit (SITU), within the Nuffield Department of Surgery, Professor of Surgical Sciences & Breast Cancer and Honorary Consultant Surgeon at the Oxford University Hospitals NHS Foundation Trust.
He is also Visiting Professor of Surgical Oncology at King’s College London and Visiting Professor of Surgery at the University of Hong Kong. He is an oncoplastic breast surgeon and his research focuses on developing and evaluating novel techniques for cancer surgery, including a novel magnetic technique for sentinel node biopsy and lesion localization, which he developed. In 2015, he was awarded a prestigious Hunterian Professorship by the Royal College of Surgeons of England and in 2019 he was appointed as one of the Royal College of Surgeons of England, Research Professors.
Michael is Vice President (and President elect) of the British Association of Surgical Oncology (BASO), a Member of Council of Breast Surgery International (BSI) and a committee member of the British Breast Group. He is also an examiner for the European Board of Surgery examinations.
Contrast-enhanced ultrasound for abdominal image-guided procedures
Wilsen CB. et al, (2023), Abdominal Radiology
Beyond the AJR: The Emerging Role of Radiofrequency Ablation in the Treatment of Low-Risk Papillary Microcarcinoma of the Thyroid
Douek ML. and Lu DSK., (2022), American Journal of Roentgenology, 219
The Use of Machine Learning to Reduce Overtreatment of the Axilla in Breast Cancer: Retrospective Cohort Study.
Jozsa F. et al, (2022), JMIR Perioper Med, 5
The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules.
Hu TX. et al, (2022), Thyroid, 32, 905 - 916
Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression.
Ruchalski K. et al, (2022), Cancer Imaging, 22